Combination of bortezomib, thalidomide, and dexamethasone in the treatment of relapsed, refractory IgD multiple myeloma. [electronic resource]
Producer: 20051005Description: 567-9 p. digitalISSN:- 1042-8194
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Boronic Acids -- administration & dosage
- Bortezomib
- Dexamethasone -- administration & dosage
- Disease-Free Survival
- Fatal Outcome
- Humans
- Immunoglobulin D -- blood
- Male
- Middle Aged
- Multiple Myeloma -- blood
- Pyrazines -- administration & dosage
- Recurrence
- Remission Induction -- methods
- Salvage Therapy
- Thalidomide -- administration & dosage
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.